There are two different Zepbound pens, they hold different numbers of doses, they cost wildly different amounts, and you cannot buy them in the same places. Almost every pricing mix-up people run into with Zepbound traces back to that.

This guide is about the device, not the drug. It covers how many doses each pen actually holds, how many pens a 28-day month takes at each strength, what the KwikPen costs direct from Lilly versus at a pharmacy counter, what the list price is and where it applies, and what pen needles add. For the brand’s full dose-by-dose self-pay ladder see our Zepbound cost guide. Every figure below was verified on Lilly’s, FDA’s, CMS’s and retailer pages on September 4, 2026.

What Does a Zepbound KwikPen Cost Without Insurance?

Zepbound pen option (one 28-day month)LowTypicalHigh
KwikPen 2.5 mg, LillyDirect self-pay (1 pen)$299$299$299
KwikPen 5 mg, LillyDirect self-pay (1 pen)$399$399$399
KwikPen 7.5 mg, LillyDirect self-pay (1 pen)$449$449$499
KwikPen 10, 12.5 or 15 mg, LillyDirect self-pay (1 pen)$449$449$699
KwikPen 2.5 mg at a retail pharmacy counter$490$655$655
Single-dose Pen carton, cash (4 pens)$1,051$1,069$1,086
Single-dose Pen carton with commercial coverage (4 pens)$25$25$25

The KwikPen self-pay rows come from Lilly’s LillyDirect Zepbound page. The High column on 7.5 mg and above is Lilly’s regular price, which applies when the Self Pay Journey Program conditions are not met. The retail row is SingleCare’s published average retail and card price for one 2.4 mL KwikPen. The single-dose Pen cash row spans CMS acquisition cost at the bottom, the Drugs.com cash price in the middle and Lilly’s own published list price at the top.

How Many Doses a Pen Holds, and How Many Pens a Month Takes

This is the fact that makes the KwikPen’s price make sense, and it is worth getting from the label rather than from a summary.

The FDA-approved Zepbound labeling, revised August 2026, lists the single-patient-use KwikPen as a 2.4 mL device containing four doses. The total strength per pen scales with the dose: 10 mg per 2.4 mL for the 2.5 mg dose, 20 mg for 5 mg, 30 mg for 7.5 mg, 40 mg for 10 mg, 50 mg for 12.5 mg and 60 mg for the 15 mg dose. Each injection is 0.6 mL.

Zepbound is injected once weekly. Four doses in one device therefore equals one 28-day month, at every single strength, and LillyDirect’s terms say exactly that: a month is 28 days and one single-patient-use KwikPen. There is no strength where you need two.

The older single-dose Pen works the opposite way. It is one dose per pen at 0.5 mL, so a 28-day month is four pens in a carton, and Lilly’s savings terms define the month as up to four single-dose pens. The single-dose Vial follows the single-dose Pen’s math at four vials per month.

FDA approved the label expansion adding the KwikPen on February 23, 2026, which is why the device is new to most people even though Lilly has used KwikPens for other medicines for years.

Where You Can Buy Each Format, and Where You Cannot

The three formats sit in three different channels, and this is the practical heart of the price difference.

The KwikPen is the only format available in both channels. Lilly’s product page labels it “Select insurance accepted, Self-pay accepted, Free delivery, Pickup available” through LillyDirect. When Lilly launched it in February 2026 it was LillyDirect-only for self-pay patients; that has since widened. CMS’s National Average Drug Acquisition Cost file, which surveys what chain and independent pharmacies actually pay for drugs, now carries KwikPen rows effective August 19, 2026, and SingleCare publishes a retail counter price for it. Both are evidence that ordinary pharmacies are stocking it.

The single-dose Vial cannot be bought at a pharmacy at all. Lilly labels it “Exclusively available through LillyDirect” and “Self-pay only.” You cannot run it through insurance and no retail pharmacy sells it. CMS’s acquisition file carries no vial row at all, which is exactly what you would expect from a product that never enters retail purchasing. Our Zepbound vials cost guide covers that channel and its syringe costs.

The single-dose Pen has no self-pay price anywhere. LillyDirect lists it as “Insurance accepted” with an insurance price of as low as $25 a month for up to a three-month prescription, and no cash ladder. If you are uninsured, this is not your format. If your plan covers Zepbound, it is almost certainly your cheapest one.

So the short version: uninsured buyers choose between the KwikPen and the Vial at identical prices. Insured buyers whose plan covers Zepbound should be looking at the single-dose Pen. The KwikPen is the only one that plays in both worlds.

What Drives the Price

Device, not dose. A 15 mg KwikPen and a 2.5 mg KwikPen are the same piece of hardware holding different concentrations. Lilly’s self-pay ladder stops climbing at $449 from 7.5 mg upward, so cost per milligram collapses as you titrate while the monthly bill does not move.

The 45-day refill window. The $449 price on 7.5 mg and above is a Zepbound Self Pay Journey Program price conditioned on refilling within 45 days of your previous delivery. Miss it and you pay Lilly’s regular price for that fill, which is $499 at 7.5 mg and $699 at 10 mg and above. That is a $50 to $250 penalty on a calendar slip.

Channel. The same 2.5 mg KwikPen is $299 from Lilly and about $655 average retail at a pharmacy counter, discounted to roughly $490 with a free SingleCare card. Manufacturer-direct wins by roughly $190 to $356 a month on the starting dose. Worth a caution here: SingleCare’s per-pharmacy rows are session-dependent and moved between two reads of the same page on the same day, with one read returning figures in the $515 to $530 band. Treat the retail counter number as an order-of-magnitude marker, not a quote. Our GoodRx vs. SingleCare guide explains where discount cards do and do not win.

List price, and which format it describes. Lilly’s pricing-disclosure site gives the Zepbound list price, or wholesale acquisition cost, as $499 to $1,086.37 per fill, citing AnalySource WAC data accessed January 1, 2026. Lilly does not break that range out by device. CMS’s acquisition file suggests the natural reading: in the data effective August 19, 2026, pharmacies paid about $482 for a KwikPen at 2.5 mg through 7.5 mg, about $672 to $678 for a KwikPen at 10 mg through 15 mg, and about $1,051 for a carton of four single-dose Pens. The bottom of Lilly’s list-price range tracks the KwikPen and the top tracks the single-dose Pen carton.

Retail cash for the single-dose Pen carton. Drugs.com lists $1,069.06 for a carton of four single-dose pens at every strength as of September 2026. That figure sits neatly between the $1,051 CMS acquisition cost and the $1,086.37 list price, which is what a real, unsubsidised brand cash price should look like. Drugs.com carries no KwikPen row, only vial and single-dose Pen rows.

Pen Needle Costs, and Which Format Includes Them

The KwikPen ships without needles. Lilly’s listing says “Pen needle purchase required,” the same way the Vial listing says “Needle and syringe purchase required.” Only the single-dose Pen says “Needle included in each Pen.”

You need one pen needle per injection, so four per 28-day month. A box of 90 BD Nano Ultra-Fine 32G 4 mm pen needles was $39.99 at Diabetic Warehouse on September 4, 2026, which works out to about 44 cents each and roughly $1.78 a month. We found the same box listed lower at other online diabetes supply retailers, so shop it. At four a month, one box lasts about 22 months.

That is the entire hidden cost of the KwikPen, and it is under two dollars a month against a $299 to $449 drug bill. Anyone telling you the pen needles meaningfully change the format math is wrong. What actually changes the math is which channel you buy in and whether you refill on time.

Cash Price vs. Insurance

If your commercial plan covers Zepbound, the single-dose Pen at about $25 a month with the manufacturer savings card is the cheapest route available to anyone, full stop. That is roughly a twelfth of the KwikPen self-pay price.

If your plan excludes weight-management drugs, the KwikPen self-pay ladder becomes your real price, and Lilly runs a separate savings card for commercially insured patients whose plan does not cover the KwikPen. Our Zepbound savings card cost guide breaks down which card applies to which format and the fill limits on each.

Medicare and Medicaid beneficiaries are excluded from commercial manufacturer cards. Lilly runs a Medicare GLP-1 Bridge program capped at $50 a month for eligible Part D patients with a weight-management prescription, and its terms note that injection supplies are sold separately.

Self-pay purchases do not count toward a deductible or out-of-pocket maximum, which matters if you expect to hit your maximum this year anyway. Our fair price checker is useful for sanity-checking the surrounding costs, like the self-pay office visit that gets you the prescription.

How to Pay Less

  1. Buy direct from Lilly rather than at a counter. On the 2.5 mg KwikPen that is $299 against about $655 average retail, and no discount card closed that gap in our September 2026 checks.

  2. Set a refill reminder the day your pen arrives. The 45-day window is worth $50 to $250 a month on 7.5 mg and above. It is the highest-value calendar entry in this guide.

  3. Ask your prescriber which format the prescription names before it is sent. Vial, KwikPen and single-dose Pen are written differently and routed differently, and switching after the fact means a new prescription. Our cheapest way to get Zepbound guide walks the decision.

  4. Buy pen needles online in a box of 90, not monthly at the pharmacy. One box covers most of two years for under $40.

  5. Price the prescribing and follow-up visits separately. A free or sliding-scale clinic can handle the visit cheaply, and if a related bill gets out of hand, negotiating medical bills works.

  6. Recheck before every refill. Lilly cut vial prices in December 2025 and added the KwikPen in February 2026. This price list is not stable.

Bottom Line

One Zepbound KwikPen is one month, at every dose, and it costs $299 to $449 self-pay through LillyDirect as of September 2026. That is the same price as four single-dose vials, so between those two formats the choice is handling preference, not money.

The expensive pen is the other one. A carton of four single-dose Pens runs about $1,069 in cash at a pharmacy against a $1,086.37 list price, and it only becomes cheap, at roughly $25 a month, when commercial insurance is paying. Which pen you are being quoted is the whole question. For how tirzepatide compares against the rest of the class, see our GLP-1 cost guide and our tirzepatide molecule guide.